China verfügt bereits über eine Einzelröhrchen-Nukleinsäuretestkapazität von mehr als 100 Millionen Tuben pro Tag

Im Oktober 13, at the press conference of the Joint Prevention and Control Mechanism of the State Council, Liang Wannian, head of the expert group of the National Health Commission’s Leading Group for Epidemic Response and Disposal, said that the key to the prevention and control of the COVID-19 epidemic is “Früherkennung”, und Nukleinsäuretests is the key to early detection. It is an important tool for diagnosing infected persons, especially in determining infected persons, which is a gold standard.

China already has a strong nucleic acid testing capability, and now it can have a single-tube testing capability of more than 100 million tubes a day – “Das heißt, if it is a 1:10 mixed test, more than one billion people can be tested a day, which is a remarkable ability.” Liang Wannian said that practice has proved that nucleic acid testing has played an important role in the early detection of domestic epidemics.